These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 20104850

  • 1. Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonist.
    Frantz MC, Rodrigo J, Boudier L, Durroux T, Mouillac B, Hibert M.
    J Med Chem; 2010 Feb 25; 53(4):1546-62. PubMed ID: 20104850
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an "easy guide" to receptor pharmacology.
    Chini B, Manning M, Guillon G.
    Prog Brain Res; 2008 Feb 25; 170():513-7. PubMed ID: 18655904
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor.
    Macion-Dazard R, Callahan N, Xu Z, Wu N, Thibonnier M, Shoham M.
    J Pharmacol Exp Ther; 2006 Feb 25; 316(2):564-71. PubMed ID: 16234409
    [Abstract] [Full Text] [Related]

  • 11. Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin.
    Gimpl G, Postina R, Fahrenholz F, Reinheimer T.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):9-16. PubMed ID: 15740719
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and structure-activity relationships of amide derivatives of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetic acid as selective arginine vasopressin V2 receptor agonists.
    Tsukamoto I, Koshio H, Kuramochi T, Saitoh C, Yanai-Inamura H, Kitada-Nozawa C, Yamamoto E, Yatsu T, Shimada Y, Sakamoto S, Tsukamoto S.
    Bioorg Med Chem; 2009 Apr 15; 17(8):3130-41. PubMed ID: 19321349
    [Abstract] [Full Text] [Related]

  • 13. Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist.
    Ring RH, Schechter LE, Leonard SK, Dwyer JM, Platt BJ, Graf R, Grauer S, Pulicicchio C, Resnick L, Rahman Z, Sukoff Rizzo SJ, Luo B, Beyer CE, Logue SF, Marquis KL, Hughes ZA, Rosenzweig-Lipson S.
    Neuropharmacology; 2010 Jan 15; 58(1):69-77. PubMed ID: 19615387
    [Abstract] [Full Text] [Related]

  • 14. LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism.
    Frantz MC, Pellissier LP, Pflimlin E, Loison S, Gandía J, Marsol C, Durroux T, Mouillac B, Becker JAJ, Le Merrer J, Valencia C, Villa P, Bonnet D, Hibert M.
    J Med Chem; 2018 Oct 11; 61(19):8670-8692. PubMed ID: 30199637
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges.
    Chini B, Manning M.
    Biochem Soc Trans; 2007 Aug 11; 35(Pt 4):737-41. PubMed ID: 17635137
    [Abstract] [Full Text] [Related]

  • 18. Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells.
    Tahara A, Tsukada J, Tomura Y, Wada Ki, Kusayama T, Ishii N, Yatsu T, Uchida W, Tanaka A.
    Br J Pharmacol; 2000 Jan 11; 129(1):131-9. PubMed ID: 10694212
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban.
    Manning M, Cheng LL, Stoev S, Wo NC, Chan WY, Szeto HH, Durroux T, Mouillac B, Barberis C.
    J Pept Sci; 2005 Oct 11; 11(10):593-608. PubMed ID: 15880385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.